Active	Status	Sponsor type	Region	Phase	Filter
3 Active 4 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Xing, Wenge
NCT06581107: Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Lung Cryablation Procedures	Not yet recruiting	N/A	20	RoW	CT-fluoroscopy guided master-slave intervetional robot-assisted lung Cryoablation	Tianjin Medical University Cancer Institute and Hospital, Wuhan United Imaging Surgical co., ltd.	Lung Cancer, Thoracic Cancer	12/24	02/25
Yu, Haipeng
TIKET, NCT06487663: TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors	Recruiting	N/A	40	RoW	TACE with ICI	Tianjin Medical University Cancer Institute and Hospital	Hepatocellular Carcinoma Non-resectable, Cholangiocarcinoma Non-resectable, Liver Metastases, Liver Malignant Tumors	10/25	10/26
NCT06581107: Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Lung Cryablation Procedures	Not yet recruiting	N/A	20	RoW	CT-fluoroscopy guided master-slave intervetional robot-assisted lung Cryoablation	Tianjin Medical University Cancer Institute and Hospital, Wuhan United Imaging Surgical co., ltd.	Lung Cancer, Thoracic Cancer	12/24	02/25